Substrate Selectivity of Coumarin Derivatives by Human CYP1 Enzymes : In Vitro Enzyme Kinetics and In Silico Modeling
Juvonen, R. O., Ahinko, M., Jokinen, E. M., Huuskonen, J., Raunio, H., & Pentikäinen, O. T. (2021). Substrate Selectivity of Coumarin Derivatives by Human CYP1 Enzymes : In Vitro Enzyme Kinetics and In Silico Modeling. ACS Omega, 6(17), 11286-11296. https://doi.org/10.1021/acsomega.1c00123
Published inACS Omega
DisciplineOrgaaninen kemiaSolu- ja molekyylibiologiaNanoscience CenterOrganic ChemistryCell and Molecular BiologyNanoscience Center
© 2021 The Authors. Published by American Chemical Society
Of the three enzymes in the human cytochrome P450 family 1, CYP1A2 is an important enzyme mediating metabolism of xenobiotics including drugs in the liver, while CYP1A1 and CYP1B1 are expressed in extrahepatic tissues. Currently used CYP substrates, such as 7-ethoxycoumarin and 7-ethoxyresorufin, are oxidized by all individual CYP1 forms. The main aim of this study was to find profluorescent coumarin substrates that are more selective for the individual CYP1 forms. Eleven 3-phenylcoumarin derivatives were synthetized, their enzyme kinetic parameters were determined, and their interactions in the active sites of CYP1 enzymes were analyzed by docking and molecular dynamic simulations. All coumarin derivatives and 7-ethoxyresorufin and 7-pentoxyresorufin were oxidized by at least one CYP1 enzyme. 3-(3-Methoxyphenyl)-6-methoxycoumarin (19) was 7-O-demethylated by similar high efficiency [21–30 ML/(min·mol CYP)] by all CYP1 forms and displayed similar binding in the enzyme active sites. 3-(3-Fluoro-4-acetoxyphenyl)coumarin (14) was selectively 7-O-demethylated by CYP1A1, but with low efficiency [0.16 ML/(min mol)]. This was explained by better orientation and stronger H-bond interactions in the active site of CYP1A1 than that of CYP1A2 and CYP1B1. 3-(4-Acetoxyphenyl)-6-chlorocoumarin (20) was 7-O-demethylated most efficiently by CYP1B1 [53 ML/(min·mol CYP)], followed by CYP1A1 [16 ML/(min·mol CYP)] and CYP1A2 [0.6 ML/(min·mol CYP)]. Variations in stabilities of complexes between 20 and the individual CYP enzymes explained these differences. Compounds 14, 19, and 20 are candidates to replace traditional substrates in measuring activity of human CYP1 enzymes. ...
PublisherAmerican Chemical Society (ACS)
Publication in research information system
MetadataShow full item record
Additional information about fundingThe research was funded by Jenny and Antti Wihuri Foundation, Emil Aaltonen Foundation (M.A.), and The Instrumentarium Science Foundation (E.M.J.). The Finnish IT Center for Science (CSC) is acknowledged for generous computational resources (O.T.P.; Projects jyy2516 and jyy2585).
Showing items with similar title or keywords.
Juvonen, Risto O.; Ahinko, Mira; Huuskonen, Juhani; Raunio, Hannu; Pentikäinen, Olli (Informa Healthcare, 2019)1. Cytochrome P450 (CYP) enzymes constitute an essential xenobiotic metabolizing system that regulates the elimination of lipophilic compounds from the body. Convenient and affordable assays for CYP enzymes are important ...
Juvonen, Risto O.; Jokinen, Elmeri M.; Huuskonen, Juhani; Kärkkäinen, Olli; Raunio, Hannu; Pentikäinen, Olli T. (Informa Healthcare, 2021)1.CYP2A13 enzyme is expressed in human extrahepatic tissues, while CYP2A6 is a hepatic enzyme. Reactions catalyzed by CYP2A13activate tobacco-specificnitrosamines and some other toxic xenobioticsin lungs. 2.To compare ...
Tossavainen, Helena; Raulinaitis, Vytas; Kauppinen, Linda; Pentikäinen, Ulla; Maaheimo, Hannu; Permi, Perttu (Frontiers Research Foundation, 2018)Lysostaphin from Staphylococcus simulans and its family enzymes rapidly acquire prominence as the next generation agents in treatment of S. aureus infections. The specificity of lysostaphin is promoted by its C-terminal ...
Determining the substrate specificity of two lysostaphin enzyme family members using NMR spectroscopy Jartti, Minne (2020)Yksi merkittävimmistä ihmisen patogeeneista on Staphylococcus aureus-bakteeri. Se aiheuttaa erityyppisiä vakavia infektioita kuten verenmyrkytystä ja sydämen sisäkalvon tulehdusta, sekä lievempiä ihotulehduksia ja ...
Koponen, Marja (2016)Koponen, M. 2016. Lääkevalmisteet ja ravintolisät suomalaisessa kilpaurheilussa. Terveystieteiden laitos, Jyväskylän yliopisto, liikuntalääketieteen pro gradu -tutkielma, 56 s, 5 liitettä. Aikaisemmat tutkimukset ovat ...